Dr. F. John Mills Joins Intelsius’ Board of Directors as Non-Executive Chair

By Intelsius, PRNE
Tuesday, June 14, 2011

YORK, England, June 15, 2011 -

Intelsius, a global manufacturer and distributor of
environmentally safe, temperature-controlled and
regulatory-compliant packaging solutions, announced today that it
has appointed Dr. F. John Mills, M.D., Ph.D., to the company’s
board of directors as non-executive chair. Dr. Mills joins
Intelsius with more than 25 years of executive and leadership
experience in the pharmaceutical and biotech industries.

(Logo:   href="photos.prnewswire.com/prnh/20101012/DE80101LOGO">photos.prnewswire.com/prnh/20101012/DE80101LOGO

“I look forward to bringing my experience to Intelsius during
such a time of global growth,” said Dr. Mills. “The company has all
of the components for continued success in the global marketplace
including an industry-experienced management team, strong product
offerings, established partnerships and customer adoption and
endorsement around the world.”

Dr. Mills is currently Chairman of the Board for BioStorage
Technologies, a premier service provider of comprehensive sample
management services for biological samples collected during
clinical research. Mills co-founded the company in 2003 and also
served as CEO before resigning from the position in late 2010. In
2009, Dr. Mills was appointed to the board of directors for
ChanTest Corporation, a leading provider of cardiac safety, ion
channel and GPCR services and products. In addition, Dr. Mills is a
member of the board of directors for Bostech Corporation, a
healthcare interoperability organization; and also serves as a
strategic advisor to Popper and Company, an M&A advisory and
specialty consulting firm.

Prior to founding BioStorage Technologies, Dr. Mills held roles
of increasing responsibility at Covance, where he served as the
Corporate Senior Vice President and President, Clinical Support
Services. In addition to Covance, Dr. Mills has held senior
management positions at Corning and Janssen Pharmaceutical.

“We greatly value Dr. Mills’ industry insight, knowledge of the
global biotechnology and pharmaceutical industries, and
specifically his expertise in temperature management technologies,”
said David Walsh, founder and CEO of Intelsius. “We are excited he
has elected to join our Board of Directors and we know his
contributions and talents will make an enormous impact on our
business moving forward.”

Dr. Mills received his M.D. from Cambridge University and his
Ph.D. in endocrinology from Surrey University in the United
. He holds diplomas in pharmaceutical medicine, aviation
medicine and marketing and has authored more than 40 scientific
papers as well as a textbook on aviation medicine.

About Intelsius

Incorporated in 1998, Intelsius is a subsidiary of DGP Group
Ltd. Intelsius specializes in the design, manufacture and supply of
temperature-controlled packaging and regulatory-compliant sample
transport solutions. With a strong focus on developing
environmentally sustainable products and procedures, the company
offers eco-friendly ways to ensure the integrity of customers’
products and samples. Intelsius has a growing global presence, with
manufacturing facilities, distribution hubs and local offices
situated throughout the world, including North America, Europe and

For more information contact:
Michael Clark
Miller Brooks, Inc.


will not be displayed